Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tanghøj

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Clinical Psychopharmacology|January 1, 1993
A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depressionS A Montgomery, J G Rasmussen, P Tanghøj
Psychopharmacology|August 20, 2002
Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depressionP Bech, P Tanghøj, H F Andersen, et al.
Acta Psychiatrica Scandinavica|June 22, 2010
Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangleP Bech, P Tanghøj, K Andreasson, et al.
International Clinical Psychopharmacology|March 1, 1994
The optimal dosing regimen for citalopram--a meta-analysis of nine placebo-controlled studiesS A Montgomery, V Pedersen, P Tanghøj, et al.
International Clinical Psychopharmacology|June 1, 1992
Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depressionS A Montgomery, J G Rasmussen, K Lyby, et al.
Pharmacopsychiatry|November 22, 2007
Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidolB Gallhofer, P Jaanson, A Mittoux, et al.
Pharmacopsychiatry|December 10, 2003
The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depressionJ Bent-Hansen, M Lunde, R Klysner, et al.
Seminars in Dermatology|June 1, 1989
Impact of individual factors on clinical patch test results with special reference to ageJ Christophersen, T Menné, P Tanghøj, et al.
Contact Dermatitis|November 1, 1989
Clinical patch test data evaluated by multivariate analysis. Danish Contact Dermatitis GroupJ Christophersen, T Menné, P Tanghøj, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 8, 2010
Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidoneM A Crocq, D Naber, M H Lader, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Clinical Psychopharmacology|January 1, 1993
A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depressionS A Montgomery, J G Rasmussen, P Tanghøj
Psychopharmacology|August 20, 2002
Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depressionP Bech, P Tanghøj, H F Andersen, et al.
Acta Psychiatrica Scandinavica|June 22, 2010
Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangleP Bech, P Tanghøj, K Andreasson, et al.
International Clinical Psychopharmacology|March 1, 1994
The optimal dosing regimen for citalopram--a meta-analysis of nine placebo-controlled studiesS A Montgomery, V Pedersen, P Tanghøj, et al.
International Clinical Psychopharmacology|June 1, 1992
Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depressionS A Montgomery, J G Rasmussen, K Lyby, et al.
Pharmacopsychiatry|November 22, 2007
Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidolB Gallhofer, P Jaanson, A Mittoux, et al.
Pharmacopsychiatry|December 10, 2003
The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depressionJ Bent-Hansen, M Lunde, R Klysner, et al.
Seminars in Dermatology|June 1, 1989
Impact of individual factors on clinical patch test results with special reference to ageJ Christophersen, T Menné, P Tanghøj, et al.
Contact Dermatitis|November 1, 1989
Clinical patch test data evaluated by multivariate analysis. Danish Contact Dermatitis GroupJ Christophersen, T Menné, P Tanghøj, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 8, 2010
Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidoneM A Crocq, D Naber, M H Lader, et al.
Pageof 2